In a possible first in Japan, doctors have used artificial intelligence to diagnose a rare type of leukemia and identify life-saving therapy far faster than if they had examined the genetic data manually.
According to Arinobu Tojo, professor of molecular therapy at a hospital affiliated to the University of Tokyo's Institute of Medical Science, a female patient in her 60s admitted in January 2015 was initially diagnosed with acute myeloid leukemia, a blood cancer characterized by rapid growth of abnormal white blood cells.
She underwent chemotherapy at the hospital, which successfully attacked the cancer cells.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.